Safety and Effects of Football in Skeletal Metastatic Prostate Cancer: a Subgroup Analysis of the FC Prostate Community Randomised Controlled Trial

被引:5
|
作者
Bjerre, Eik Dybboe [1 ]
Weller, Sarah [2 ]
Poulsen, Mads Hvid [3 ,4 ]
Madsen, Soren Sorensen [5 ]
Bjerre, Rie Dybboe [6 ]
ostergren, Peter Busch [7 ]
Borre, Michael [8 ]
Brasso, Klaus [9 ]
Midtgaard, Julie [1 ,10 ]
机构
[1] Univ Copenhagen, Rigshosp, Univ Hosp Ctr Hlth Res, Dept 9701,Blegdamsvej 9, DK-2100 Copenhagen, Denmark
[2] Vancouver Prostate Ctr, Prostate Canc Support Care Program, Vancouver, BC, Canada
[3] Odense Univ Hosp, Dept Urol, Odense, Denmark
[4] Odense Univ Hosp, Acad Geriatr Canc Res, Odense, Denmark
[5] Hosp South West Jutland, Dept Urol, Esbjerg, Denmark
[6] Univ Copenhagen, Herlev & Gentofte Hosp, Hellerup, Denmark
[7] Herlev & Gentofte Hosp, Dept Urol, Herlev, Denmark
[8] Aarhus Univ Hosp, Dept Urol, Aarhus, Denmark
[9] Univ Copenhagen, Copenhagen Prostate Canc Ctr, Dept Urol, Rigshosp, Copenhagen, Denmark
[10] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark
关键词
Soccer; Cancer survivor; Community; Exercise; Rehabilitation;
D O I
10.1186/s40798-021-00318-6
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
Background Skeletal metastatic disease excludes many cancer patients from participating in exercise and physical activity due to safety concerns. Empirical evidence from high-quality trials is warranted to guide clinicians and patients. Objective To evaluate the safety and potential benefits of high-impact aerobic exercise in patients with prostate cancer with skeletal metastases. Design Exploratory subgroup analysis of a pragmatic, multicentre, parallel randomised controlled trial. Setting The trial recruited 214 patients from five hospital urological departments in Denmark. Participants Patients with prostate cancer with skeletal metastases (n = 41). Intervention Six months of football training twice weekly at a local club or usual care. Both groups received brief information on physical activity recommendations at the time of randomisation. Main Outcome(s) and Measure(s) Safety, defined as falls, fractures and hospital admissions. Effects were evaluated on the primary outcome (prostate cancer-specific quality of life) and secondary outcomes (lean body mass, fat mass, hip and spine bone mineral density, and general physical and mental health). Results The original trial comprised 214 participants, 41 of whom had skeletal metastases at enrolment. Of these, 22 were allocated to football and 19 to usual care. The trial retention rate was 95% at 12 weeks and 88% at 6 months. Football participants attended 13 sessions on average at 12 weeks and 23 at 6 months. There were two falls, one in each group after 6 months, and no fractures. There were four unplanned hospital admissions in the study period, all four in the usual care group. Statistically significant between-group difference was observed in the primary outcome change in prostate cancer-specific quality of life at 12 weeks (7.6 points [95% CI 0.5 to 15.0]; P = 0.038). No statistical changes were found in the secondary outcomes. Conclusion The analysis showed that football training was safe in patients with skeletal metastatic prostate cancer and significantly improved quality of life. Larger analyses and/or trials are warranted to confirm the safety of exercise more broadly in cancer patients with skeletal metastatic disease.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial
    Uth, J.
    Hornstrup, T.
    Christensen, J. F.
    Christensen, K. B.
    Jorgensen, N. R.
    Schmidt, J. F.
    Brasso, K.
    Jakobsen, M. D.
    Sundstrup, E.
    Andersen, L. L.
    Rorth, M.
    Midtgaard, J.
    Krustrup, P.
    Helge, E. W.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 (04) : 1507 - 1518
  • [22] Exercise intervention and sexual function in advanced prostate cancer: a randomised controlled trial
    Galvao, Daniel A.
    Taaffe, Dennis R.
    Chambers, Suzanne K.
    Fairman, Ciaran M.
    Spry, Nigel
    Joseph, David
    Newton, Robert U.
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (01) : 29 - 32
  • [23] Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): A Randomised Controlled Phase 3 Trial
    Tilki, Derya
    Evans, Christopher P.
    EUROPEAN UROLOGY, 2019, 75 (03) : 535 - 536
  • [24] Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial
    Brady, Lauren
    Hayes, Brian
    Sheill, Grainne
    Baird, Anne-Marie
    Guinan, Emer
    Stanfill, Bryan
    Vlajnic, Tatjana
    Casey, Orla
    Murphy, Verena
    Greene, John
    Allott, Emma H.
    Hussey, Juliette
    Cahill, Fidelma
    Van Hemelrijck, Mieke
    Peat, Nicola
    Mucci, Lorelei
    Cunningham, Moya
    Grogan, Liam
    Lynch, Thomas
    Manecksha, Rustom P.
    McCaffrey, John
    O'Donnell, Dearbhaile
    Sheils, Orla
    O'Leary, John
    Rudman, Sarah
    McDermott, Ray
    Finn, Stephen
    PLOS ONE, 2020, 15 (12):
  • [25] Re: Radiotherapy to the Primary Tumour for Newly Diagnosed, Metastatic Prostate Cancer (STAMPEDE): a Randomised Controlled Phase 3 Trial
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2019, 202 (01): : 32 - 33
  • [26] Demonstrating the external validity of a randomised controlled trial: the design and generalizability of the protect prostate cancer trial
    Donovan, Jenny
    Young, Grace
    Walsh, Eleanor
    Metcalfe, Chris
    Lane, Athene
    Martin, Richard
    Neal, David
    Hamdy, Freddie
    TRIALS, 2017, 18
  • [27] A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening
    Gattellari, M
    Ward, JE
    PATIENT EDUCATION AND COUNSELING, 2005, 57 (02) : 168 - 182
  • [28] ANTIOXIDANT EFFECTS OF LYCOPENE IN MEN WITH PROSTATE CANCER OR BENIGN PROSTATE HYPERPLASIA: A RANDOMIZED CONTROLLED TRIAL
    van Breemen, Richard B.
    Sharifi, Roohollah
    Viana, Marlos
    Bowen, Phyllis E.
    Stacewicz-Sapuntzakis, Maria
    PHARMACEUTICAL BIOLOGY, 2012, 50 (05) : 631 - 631
  • [29] Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial
    Beynon, Rhona A.
    Richmond, Rebecca C.
    Ferreira, Diana L. Santos
    Ness, Andrew R.
    May, Margaret
    Smith, George Davey
    Vincent, Emma E.
    Adams, Charleen
    Ala-Korpela, Mika
    Wurtz, Peter
    Soidinsalo, Sebastian
    Metcalfe, Christopher
    Donovan, Jenny L.
    Lane, Athene J.
    Martin, Richard M.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 144 (08) : 1918 - 1928
  • [30] Investigating the effects of dietary and physical activity interventions on the metabolome of men with prostate cancer: The PrEvENT randomised controlled trial
    Sandu, Meda R.
    Ferreira, Diana L. Santos
    Richmond, Rebecca
    Hackshaw-McGeagh, Lucy
    Beynon, Rhona
    Martin, Richard M.
    Lane, J. Athene
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 35 - 36